AddedRisk Factors
Our debt agreements also contain financial and other covenants that may restrict our ability to take certain actions, and failure to comply with these covenants could result in an event of default and accelerate our repayment obligations. In addition, borrowings under our new credit agreement bear interest at variable rates, which exposes us to increases in interest expense if market interest rates rise. These factors could adversely affect our business, financial condition and results of operations.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
AddedRisk Factors
We manufacture certain parts and components of our products and rely on third-party suppliers for raw materials, components and finished goods. The availability, pricing and lead times of these inputs may be affected by a variety of factors, including supply and demand imbalances, supplier capacity constraints, tariffs and other trade restrictions, geopolitical developments, transportation disruptions and other supply chain constraints. Certain materials and components may be available from a limited number of suppliers, and qualifying alternative suppliers may require significant time and expense.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
AddedRisk Factors
Following the acquisition of PSS, our exposure to the cost and availability of electronic components, including memory and other semiconductor components, has increased. Significant increases in input costs, shortages of key components or extended lead times could increase our costs, disrupt production, limit our ability to meet customer demand and adversely affect our profit margins and results of operations.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
AddedRisk Factors
We may take actions to mitigate supply shortages and disruptions, including increasing inventory levels or purchasing components in advance of anticipated demand. These actions may increase our working capital requirements and expose us to greater risk of excess or obsolete inventory, particularly if customer demand, component pricing or technology trends differ from our expectations.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RemovedRisk Factors
We manufacture certain parts and components of our products and therefore require raw materials from suppliers, which could be interrupted for a variety of reasons, including availability and pricing. Our prices and lead times for raw materials and other components necessary for production have continued to fluctuate over the past year, including increased raw production costs, increased wage rates, and extended lead times. Significant increases could adversely affect our profit margins and results of operations. Changes in trade policies; supply chain disruptions; and the imposition of duties and tariffs and potential retaliatory countermeasures could adversely impact the price or availability of raw materials, which could adversely affect our profit margins and results of operations. In addition, labor shortages or an increase in the cost of labor could adversely affect our profit margins and results of operations. Due to competitive pressures or other factors, we may not be able to pass along increased raw material and component part costs to our customers in the form of price increases or our ability to do so could be delayed, which could adversely impact our business and financial results.
Read it in 10-K Sep 4, 2025 at sec.govopen_in_new
RemovedRisk Factors
On July 4, 2025, the U.S. government enacted tax legislation commonly referred to as the One Big Beautiful Bill Act (“OBBBA”). The OBBBA made permanent or extended several provisions from the Tax Cuts and Jobs Act of 2017, including restoration of 100% bonus depreciation, an EBITDA-based limitation on interest expense deductions, and immediate expensing of domestic research and development expenditures. Future changes to these or other tax laws, as well as related regulations and interpretations, could materially affect our financial results.
Read it in 10-K Sep 4, 2025 at sec.govopen_in_new
RewordedRisk Factors
While we have implemented certain cost containment measures and measures, selective price increases, as well as taken increases and other actions intended to offset recent mitigate inflationary pressures in our and supply chain, we chain pressures, these actions may not be able sufficient to offset all of the increases in our operational costs, which could adversely impact our business costs or the effects of supply shortages and financial results. disruptions.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
When we decide to sell a business or specific assets, we We may be unable to do so complete a divestiture on satisfactory terms or within our anticipated timeframe, and even after reaching a definitive agreement to sell a business, the sale is typically transactions may be subject to pre-closing conditions which that may not be satisfied.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
We have retained In addition, we may also retain responsibility for and have agreed agree to indemnify buyers against certain contingent liabilities related to several businesses that we sell and the resolution of any contingencies could have sold. a material adverse impact on our financial results.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
Recent Acquisitions place significant demands on management, operational, and future acquisitions will financial resources and may require the integration of operations, sales and marketing, finance and administrative functions, and information technology, finance, and administrative operations, which could decrease the time and resources available to focus on our existing businesses and other growth strategies.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our historical growth has included acquisitions, including, for instance, the acquisition of the PSS business, and acquisitions and may continue to be part of our future growth strategy includes acquisitions. strategy.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
The failure to properly identify, integrate effectively manage acquisitions, divestitures and grow acquired companies, and to manage contingent liabilities from divested businesses other portfolio management activities could adversely affect our business and financial results.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
Therefore, the voting shareholders have control in most matters requiring approval or acquiescence by shareholders, including the composition of our Board of Directors and many corporate actions, and their interests may not align with those of the non-voting shareholders.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
Sales Because a significant portion of our business is conducted outside of the United States, our sales and purchases in currencies other than the U.S. dollar expose us to fluctuations in foreign currencies relative to the U.S. dollar, and which may adversely affect our financial results.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
We cannot assure guarantee that we will be able to successfully identify and integrate acquisitions, that these acquisitions acquired businesses will operate profitably, or that we will be able to achieve the desired anticipated sales growth growth, synergies or other benefits from acquisitions.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
Raw material material, component and other cost inflation inflation, as well as product shortages supply shortages, could adversely affect our business and financial results.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedRisk Factors
We have goodwill of $676.9 $686.0 million and other intangible assets of $105.4 $97.8 million as of July 31, 2025, 2026, which represent 45.1% 42.3% of our total assets, and we have recognized impairment charges in the past.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
AddedMD&A
The Company continues to evaluate developments related to tariff policy and related administrative proceedings. While we have received certain refunds for tariffs previously paid, we expect to continue to incur ongoing tariff costs while actively pursuing additional refunds. Any such potential refunds of tariffs previously paid remain subject to ongoing administrative processes and uncertainty regarding their timing, availability, and ultimate amount.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
AddedMD&A
Subsequent to the fiscal year-end, on August 3, 2026, the Company completed the acquisition of Honeywell’s PSS business for a cash purchase price of $1.4 billion, subject to customary post-closing adjustments. The transaction was funded through a combination of cash on hand, immediate borrowings under our new credit agreement, and private placement debt. This funding event included the full drawdown of the $500 million term loan facility alongside initial drawings of approximately $300 million under the revolving credit facility. Concurrently with the closing of the PSS acquisition, the available borrowing capacity under our revolving credit facility automatically expanded from an interim cap of $300 million to the full $500 million facility limit.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
AddedMD&A
Net increase (decrease) in cash and cash equivalents $ 12,800 $ (75,769) $ 98,586
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RemovedMD&A
Notwithstanding the uncertain situation relating to tariffs, we believe our financial strength positions us well to continue investing in acquisitions and organic growth opportunities, such as expanded sales channels, marketing programs, and research and development (“R&D”). We remain focused on driving sustainable efficiency gains and automation across our operations and selling, general and administrative (“SG&A”) functions, while also returning capital to our shareholders through dividends and share repurchases. At July 31, 2025, we had cash of $174.3 million, as well as a credit agreement with $198.1 million available for future borrowing, which can be increased up to $1,093.1 million at the Company's option and subject to certain conditions, for total available liquidity of $1,267.4 million.
Read it in 10-K Sep 4, 2025 at sec.govopen_in_new
RewordedMD&A
The Company believes it is reasonably possible that the amount of gross unrecognized tax benefits could be reduced by up to $3.1 $2.6 million in the next 12 months as a result of the resolution of worldwide tax matters, tax audit settlements, amended tax filings, and/or statute expirations, which would be the maximum amount that would be recognized as an income tax benefit in the consolidated statements of income.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
Americas & Asia net sales increased 12.1% 11.4% to $1,106.6 million in fiscal 2026 compared to $993.7 million in fiscal 2025 compared to $886.5 million in fiscal 2024, 2025, which consisted of organic sales growth of 4.8% and 7.5%, sales growth from acquisitions of 8.3%, which were partially offset by a decrease 3.3%, and an increase from foreign currency translation of 0.6% and a decrease due to a divestiture of 0.4%. 0.6%.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
Net sales increased 12.8% 9.8% to $1,661.6 million in fiscal 2026 compared to $1,513.6 million in fiscal 2025 compared to $1,341.4 million in fiscal 2024, 2025, which consisted of organic sales growth of 2.6% 5.3%, an increase from foreign currency translation of 2.3%, and sales growth from acquisitions of 10.5%, which was partially offset by a decrease of 0.3% due to divestitures. 2.2%.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
GAAP, References in this Annual Report on Form 10-K to “organic sales” refer to sales calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), excluding the impact of foreign currency translation, sales recorded from divested companies up to the first anniversary of their divestiture and sales recorded from acquired companies prior to the first anniversary date of their acquisition.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
Organic sales growth reflected strong execution of our commercial strategies, supported by steady industrial demand in North America, continued expansion in key end markets across Latin America, America and resilient increasing demand in Asia despite mixed economic conditions in certain countries. throughout Asia.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
Our business has incurred, and expects to we expect will continue to incur, incur additional costs as it relates related to these incremental tariffs for the foreseeable future. and related countermeasures.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
Gross margin increased 10.6% 13.0% to $859.8 million in fiscal 2026 compared to $760.8 million in fiscal 2025 compared to $687.9 million in fiscal 2024. 2025.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
R&D expenses increased 17.9% 17.7% to $94.0 million in fiscal 2026 compared to $79.9 million in fiscal 2025 compared to $67.7 million in fiscal 2024. 2025.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
SG&A expenses increased 17.9% 13.1% to $502.3 million in fiscal 2026 compared to $444.3 million in fiscal 2025 compared to $376.7 million in fiscal 2024. 2025.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
The organic sales increase was primarily driven by higher demand realized throughout Asia with continued growth from electronics manufacturing services providers, technology companies, and industrial suppliers across Japan, India, Malaysia and Singapore. the region.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in R&D spending in fiscal 2025 2026 was primarily due to the acquisition acquisitions of Gravotech, and, to a lesser extent, Microfluidic Solutions and Mecco, and an increase in R&D headcount within the Company's Company’s organic business.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new
RewordedMD&A
Investment and other income was $5.6 million in fiscal 2026 compared to $5.2 million in fiscal 2025 compared to $7.6 million in fiscal 2024. 2025.
Read it in 10-K Sep 3, 2026 at sec.govopen_in_new